Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Capital Employed (2016 - 2025)

Standard Biotools (LAB) has disclosed Return on Capital Employed for 15 consecutive years, with 0.36% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 9.0% to 0.36% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.36%, a 9.0% decrease, with the full-year FY2024 number at 0.44%, down 13.0% from a year prior.
  • Return on Capital Employed was 0.36% for Q3 2025 at Standard Biotools, down from 0.33% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.25% in Q2 2024 to a low of 0.36% in Q4 2024.
  • A 5-year average of 0.31% and a median of 0.31% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -11bps in 2021, then grew 3bps in 2024.
  • Standard Biotools' Return on Capital Employed stood at 0.29% in 2021, then decreased by -10bps to 0.32% in 2022, then dropped by -7bps to 0.35% in 2023, then decreased by -5bps to 0.36% in 2024, then rose by 0bps to 0.36% in 2025.
  • Per Business Quant, the three most recent readings for LAB's Return on Capital Employed are 0.36% (Q3 2025), 0.33% (Q2 2025), and 0.34% (Q1 2025).